Cardinal Health Inc. Stock
Price
Target price
€97.74
€97.74
-1.030%
-1.02
-1.030%
€110.67
23.08.24 / Tradegate
WKN: 880206 / Symbol: CAH / Name: Cardinal Health / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cardinal Health Inc. Stock
A loss of -1.030% shows a downward development for Cardinal Health Inc..
Our community is currently high on Cardinal Health Inc. with 14 Buy predictions and 3 Sell predictions.
As a result the target price of 110 € shows a slightly positive potential of 12.54% compared to the current price of 97.74 € for Cardinal Health Inc..
Pros and Cons of Cardinal Health Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cardinal Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardinal Health Inc. | -1.030% | -1.927% | 10.666% | 24.351% | 8.600% | 120.036% | 154.333% |
| CVS Health Corp. | 0.980% | -0.831% | -1.723% | -14.120% | -26.731% | -27.117% | -3.066% |
| AmerisourceBergen Corp. | -1.150% | -1.667% | 2.758% | 29.813% | 15.460% | 108.235% | 182.785% |
| McKesson Corp. | -2.160% | -0.765% | -8.651% | 27.088% | 19.106% | 186.187% | 269.807% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01
Cardinal Health, trading under the ticker CAH, presents a complex financial picture within the Food & Drug Retailing industry. Recent financial statements indicate both positive aspects and considerable challenges. While the company showcases substantial revenue and a respectable market capitalization, it struggles with high debts and negative stockholder equity, raising concerns about its financial stability.
*Pros: *
Revenue Growth: Cardinal Health reported total revenue of approximately $205 billion for the year ending June 30, 2023. This demonstrates strong sales momentum, indicative of the company's ability to capture market demand and expand its operations in a competitive industry.
Comments
Cardinal Health, Inc. (NYSE: CAH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $120.00 to $125.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CAH provided by MarketBeat
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $101.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for CAH provided by MarketBeat